The Walk to Defeat ALS is the ALS Association’s signature event, with funds raised directly supporting innovative research, care services, and advocacy efforts.

by Karris Harmon Mon, April 28th 2025 at 3:59 PM Updated Mon, April 28th 2025 at 6:39 PM WEAR TOPICS: ALS Veterans Advocacy Research Santa Rosa County Neurodegenerative Mandi Bailey Freddie McClurkin ...

Since Wallach’s ALS diagnosis in 2017, the couple has spearheaded arguably the most successful patient advocacy campaign this century. Since founding I Am ALS the following year, the ...

It’s scheduled for Sep. 17 at Winton Woods Park. Participants can walk as an individual or as a team to support research, advocacy, and education. For more information, click here.

He was diagnosed with ALS. Then they changed the face of medical advocacy By Juana Summers, Courtney Dorning, Elena Burnett Published June 30, 2023 at 5:01 AM EDT Listen • 11:20 Jamie Kelter ...

David Husman pledged $20 million to Nova Southeastern University to support research and other programs within the newly named David and Cathy Husman Neuroscience Institute, its Cathy J. Husman ALS ...

‘Walk to Defeat ALS’ raises research funds Saturday Taylor Liberti News10NBC Updated: September 16, 2023 - 4:22 PM Published: September 16, 2023 - 6:09 AM ...

“We have seen a significant lift in donations, which will help our urgent work to make ALS a livable disease through local care, national advocacy, and global ALS research,” a rep for the ...

Since the inception of I AM ALS, federal funding for ALS research has increased by $1 billion. Last year alone, the organization procured $321 million in federal appropriations for the disease.

Media Tackling ALS Like a Presidential Campaign A new documentary shows how patient-led advocacy is changing research. Posted August 10, 2023 | Reviewed by Gary Drevitch ...

Austin resident Carrie George is one of those patients with a rare hereditary form of ALS, and is participating in clinical research trials to help specialists study the hereditary version ...

More recently, ALS has significantly weakened his voice and Abrevaya has helped him deliver his testimony. "This is the closing argument for our lives," Wallach told House lawmakers in July 2021.